These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 31465841)
21. Increased expression of long non-coding RNA GLIDR in prostate cancer. Zhang Y; Kong Z; Zhang Y; Huang W; Wu H; Wan X; Li Y Cancer Biomark; 2017; 19(2):145-150. PubMed ID: 28211799 [TBL] [Abstract][Full Text] [Related]
22. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway. Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242 [TBL] [Abstract][Full Text] [Related]
23. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management. Ramnarine VR; Kobelev M; Gibb EA; Nouri M; Lin D; Wang Y; Buttyan R; Davicioni E; Zoubeidi A; Collins CC Eur Urol; 2019 Nov; 76(5):546-559. PubMed ID: 31445843 [TBL] [Abstract][Full Text] [Related]
24. [Long non-coding RNAs in prostate cancer: An update]. Wu PG; Zhang YX Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435 [TBL] [Abstract][Full Text] [Related]
25. Identification of 10 differently expressed lncRNAs as prognostic biomarkers for prostate adenocarcinoma. Wu ZY; Wang SG; Li Q; Zhao QS; Shao MM Math Biosci Eng; 2019 Dec; 17(3):2037-2047. PubMed ID: 32233522 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of the Long Non-Coding RNA NeSt and FOXCUT in Early Stages of Prostate Cancer Samples as Promising Biomarkers. Rostami S; Nabi M; Naghavi P; Mohammadzadeh N; Khalili A Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710451 [TBL] [Abstract][Full Text] [Related]
27. Identification of androgen response-related lncRNAs in prostate cancer. Karthikeyan SK; Xu N; Ferguson Rd JE; Rais-Bahrami S; Qin ZS; Manne U; Netto GJ; S Chandrashekar D; Varambally S Prostate; 2023 May; 83(6):590-601. PubMed ID: 36760203 [TBL] [Abstract][Full Text] [Related]
28. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications. Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368 [TBL] [Abstract][Full Text] [Related]
29. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets. Chandra Gupta S; Nandan Tripathi Y Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173 [TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications. Niu ZS; Niu XJ; Wang WH World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078 [TBL] [Abstract][Full Text] [Related]
31. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502 [TBL] [Abstract][Full Text] [Related]
32. Landscape of Noncoding RNA in Prostate Cancer. Hua JT; Chen S; He HH Trends Genet; 2019 Nov; 35(11):840-851. PubMed ID: 31623872 [TBL] [Abstract][Full Text] [Related]
33. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA. Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971 [TBL] [Abstract][Full Text] [Related]
34. Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention. Mirzaei S; Paskeh MDA; Okina E; Gholami MH; Hushmandi K; Hashemi M; Kalu A; Zarrabi A; Nabavi N; Rabiee N; Sharifi E; Karimi-Maleh H; Ashrafizadeh M; Kumar AP; Wang Y J Exp Clin Cancer Res; 2022 Jul; 41(1):214. PubMed ID: 35773731 [TBL] [Abstract][Full Text] [Related]
35. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Yang L; Lin C; Jin C; Yang JC; Tanasa B; Li W; Merkurjev D; Ohgi KA; Meng D; Zhang J; Evans CP; Rosenfeld MG Nature; 2013 Aug; 500(7464):598-602. PubMed ID: 23945587 [TBL] [Abstract][Full Text] [Related]
36. Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors. Takayama KI; Fujimura T; Suzuki Y; Inoue S Commun Biol; 2020 Jul; 3(1):393. PubMed ID: 32704143 [TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNAs: new players in prostate cancer. Cheng W; Zhang Z; Wang J Cancer Lett; 2013 Oct; 339(1):8-14. PubMed ID: 23856029 [TBL] [Abstract][Full Text] [Related]
38. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence. Wang L; Han S; Jin G; Zhou X; Li M; Ying X; Wang L; Wu H; Zhu Q Int J Oncol; 2014 Jun; 44(6):2041-9. PubMed ID: 24691949 [TBL] [Abstract][Full Text] [Related]
39. Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer. Su YJ; Yu J; Huang YQ; Yang J Int J Mol Sci; 2015 Jun; 16(6):13322-38. PubMed ID: 26110379 [TBL] [Abstract][Full Text] [Related]
40. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference? Deng J; Tang J; Wang G; Zhu YS Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28272371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]